Adam Taich is CFO at 10x Genomics, Inc. (TXG). They have made 7 open-market trades across 2 companies since 2023, most recently 2026-09-09.
CIK 0001971187
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TXG | 316,344 | $22.1M |
| SLGC | 260,227 | $546K |
| Total | $22.6M |
Shares reported on the most recent Form 4, priced at the 2026-09-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXG | SELL · 10b5-1 | 2026-09-09 | 2026-09-11 | $64.57 | $3.0M | +13.0% | +12.5% | — |
| TXG | SELL | 2026-08-24 | 2026-08-26 | $63.02 | $1.1M | +2.6% | +34.2% | — |
| TXG | SELL | 2026-05-22 | 2026-05-27 | $24.44 | $369K | +15.1% | +45.0% | +155.6% |
| TXG | SELL | 2026-02-23 | 2026-02-25 | $18.58 | $167K | +6.4% | -0.9% | +25.3% |
| TXG | SELL | 2025-11-24 | 2025-11-25 | $19.00 | $226K | -6.0% | -11.3% | +1.7% |
| TXG | SELL | 2025-08-22 | 2025-08-26 | $13.79 | $615K | -0.0% | -14.2% | +44.5% |
| TXG | SELL | 2025-05-22 | 2025-05-27 | $8.30 | $34K | +9.4% | +35.9% | +63.4% |
| SLGC | SELL | 2023-03-02 | 2023-10-02 | $2.34 | $104K | -25.7% | -7.2% | +3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.